|
Cardiovascular Pharmacology
Citations 161-170 of 640 total displayed.
|
Past content
(since Jan 1999):
|
- Editorials
Interpretation of Plasma Renin Concentration in Patients Receiving Aliskiren Therapy
- Duncan J. Campbell
Hypertension published November 5, 2007, doi:10.1161/HYPERTENSIONAHA.107.101287
[Abstract]
- Editorial Commentary
LA419, a Novel Nitric Oxide Donor, Prevents Cardiac Remodeling Via the Endothelial Nitric Oxide Synthase Pathway NO Donors as a Means of Antiremodeling
- Ludovit Paulis and Fedor Simko
Hypertension published November 5, 2007, doi:10.1161/HYPERTENSIONAHA.107.100032
[Abstract]
- Scientific Contributions
LA419, a Novel Nitric Oxide Donor, Prevents Pathological Cardiac Remodeling in Pressure-Overloaded Rats Via Endothelial Nitric Oxide Synthase Pathway Regulation
- Gema Ruiz-Hurtado, María Fernández-Velasco, Marisabel Mourelle, and Carmen Delgado
Hypertension published November 5, 2007, doi:10.1161/HYPERTENSIONAHA.107.093666
[Abstract]
- Letters to the Editor
Acarbose and Postprandial Hypotension
- Diana Gentilcore, Michael Horowitz, and Karen L. Jones
Hypertension 2007;50:e159; published online before print as doi:10.1161/HYPERTENSIONAHA.107.097717
[Full text]
- Letters to the Editor
Response to Unexpected Therapeutic Response to Spironolactone: A Prospective Debate on Aldosterone and Potassium Ion in Hypertension
- Theodore L. Goodfriend
Hypertension 2007;50:e166-164e; published online before print as doi:10.1161/HYPERTENSIONAHA.107.099671
[Full text]
- Original Articles
Blood Pressure Control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
- Karen L. Margolis, Linda B. Piller, Charles E. Ford, Mario A. Henriquez, William C. Cushman, Paula T. Einhorn, Pedro J. Colon, Sr, Donald G. Vidt, Rudell Christian, Nathan D. Wong, Jackson T. Wright, Jr, David C. Goff, Jr for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
Hypertension 2007;50:854-861; published online before print as doi:10.1161/HYPERTENSIONAHA.107.092650
[Abstract]
[Full text]
- Original Articles
Yohimbine Attenuates Baroreflex-Mediated Bradycardia in Humans
- Jens Tank, Karsten Heusser, André Diedrich, Robert J. Brychta, Friedrich C. Luft, and Jens Jordan
Hypertension 2007;50:899-903; published online before print as doi:10.1161/HYPERTENSIONAHA.107.095984
[Abstract]
[Full text]
- Scientific Contributions
Chemokine Receptor 2b Inhibition Provides Renal Protection in Angiotensin II–Salt Hypertension
- Ahmed A. Elmarakby, Jeffrey E. Quigley, Jeffrey J. Olearczyk, Aarthi Sridhar, Anthony K. Cook, Edward W. Inscho, David M. Pollock, and John D. Imig
Hypertension published October 15, 2007, doi:10.1161/HYPERTENSIONAHA.107.098806
[Abstract]
- Brief Reviews
Role of Renin-Angiotensin System Blockade in Atherosclerotic Renal Artery Stenosis and Renovascular Hypertension
- Daniel G. Hackam, J. David Spence, Amit X. Garg, and Stephen C. Textor
Hypertension published October 8, 2007, doi:10.1161/HYPERTENSIONAHA.107.097345
[Abstract]
- Original Articles
Nebivolol Induces Nitric Oxide Release in the Heart Through Inducible Nitric Oxide Synthase Activation
- Angelo Maffei, Alba Di Pardo, Rosa Carangi, Pierluigi Carullo, Roberta Poulet, Maria T. Gentile, Carmine Vecchione, and Giuseppe Lembo
Hypertension 2007;50:652-656; published online before print as doi:10.1161/HYPERTENSIONAHA.107.094458
[Abstract]
[Full text]
|
|
